Characteristic | Systemic lupus erythematosus patients | Control individuals |
---|---|---|
Number | 63 | 31 |
Female (%) | 85.7 | 67.8 |
Age, mean (range) (years) | 40.6 (21 to 67) | 31.9 (23 to 54) |
Systemic Lupus Erythematosus Disease Activity Index (mean) | 4.2 ± 0.4 |  |
Systemic Lupus Erythematosus Disease Activity Index >2 (%) | 57.2 | Â |
Elevated dsDNA antibodies (%) | 58.7 | Â |
Decreased C3 and/or C4 (%) | 31.7 | Â |
Medications (%) | Â | Â |
   Antimalarials | 73.0 |  |
   Azathioprine | 4.8 |  |
   Cyclophosphamide | 4.8 |  |
   Methotrexate | 4.8 |  |
   Mycophenolate | 30.2 |  |
Prednisone (%) | Â | Â |
   None | 36.5 |  |
   <30 mg/day | 52.4 |  |
   >30 mg/day | 11.1 |  |
No medications (%) | 14 | Â |